Annals of Indian Academy of Neurology
  Users Online: 548 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size


 
LETTER TO THE EDITOR
Year : 2010  |  Volume : 13  |  Issue : 2  |  Page : 152
 

Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy


Immunodeficiencies Unit, Hospital 12 octubre, Carretera Andalucia km 5,400, P.O. 28041, Madrid, Spain

Date of Web Publication25-Jun-2010

Correspondence Address:
Luis I Gonzalez-Granado
Immunodeficiencies Unit, Hospital 12 octubre, Carretera Andalucia km 5,400, P.O. 28041, Madrid
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-2327.64629

Rights and Permissions

 



How to cite this article:
Gonzalez-Granado LI. Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy. Ann Indian Acad Neurol 2010;13:152

How to cite this URL:
Gonzalez-Granado LI. Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy. Ann Indian Acad Neurol [serial online] 2010 [cited 2019 Jul 18];13:152. Available from: http://www.annalsofian.org/text.asp?2010/13/2/152/64629


Sir,

I read with great interest the case reported by Drs Saini and Khurana titled "Chronic relapsing inflammatory optic neuropathy". [1] I do really appreciate their contribution to the knowledge of chronic relapsing inflammatory optic neuropathy. However, after reading the case I have one main concern: long-term management. It is well known that steroids can prevent reactivation of chronic relapsing inflammatory optic neuropathy. Nonetheless, we should be aware of the severe adverse effects that long-term steroids can induce in these patients. Therefore, there is an increasing interest in the use of intravenous immunoglobulins as steroid-sparing agents, as they have been demonstrated to be effective in the treatment of idiopathic inflammatory neuropathies including Guillain-Barrι syndrome, chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy (MMN; in this case represents the gold standard for treatment). [2],[3] In the past, other steroid-sparing agents have been used with mild to severe side effects (methotrexate, cyclophosphamide, azathioprine - the most used drug within this group - and mycophenylate). [4],[5] The authors could argue that deflazacort was administered on alternate days. Nevertheless, the anti-inflammatory effect is 30% higher compared with prednisolone and a better risk/benefit ratio has only been demonstrated for the bone-sparing effect. [6]

This is why steroid sparing agents should be strongly considered (especially i.v. immunoglobulins) for the management of this condition.

 
   References Top

1.Saini M, Khurana D. Chronic relapsing inflammatory optic neuropathy. Ann Indian Acad Neurol 2010;13:61-3.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Stiebel-Kalish H, Hammel N, van Everdingen J, Huna-Baron R, Lee AG. Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy. Can J Ophthalmol 2010;45:71-5.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Nobile-Orazio E, Terenghi F. IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results. J Neurol 2005;252:I7-13.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Myers TD, Smith JR, Wertheim MS, Egan RA, Shults WT, Rosenbaum JT. Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. Br J Ophthalmol 2004;88:673-80.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001;85:1220-4.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol 1993;32:11-4.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]  



This article has been cited by
1 Authoręs reply
Saini, M., Khurana, D.
Annals of Indian Academy of Neurology. 2010; 13(2): 152-153
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

 
   Search
 
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (596 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1832    
    Printed73    
    Emailed0    
    PDF Downloaded65    
    Comments [Add]    
    Cited by others 1    

Recommend this journal